André-Michel Ballester

André-Michel Ballester

Privat kapitalinvesterare på
ArchiMed SAS
68 år
Health Technology
Consumer Services
Process Industries

Profil

Currently, André-Michel Ballester is Managing Partner at ArchiMed SAS since 2017 and Managing Partner at North American Science Associates LLC starting in 2025.
Formerly, the roles include Chief Executive Officer & Director at Sorin SpA from 2007 to 2015, Chief Executive Officer & Director at LivaNova Plc from 2015 to 2016, Chairman at Bomi Italia SpA and Suan Farma SA, Independent Director at Mauna Kea Technologies SA from 2014 to 2015, Director at IMI Intelligent Medical Implants AG, Director at Carmat SA from 2009 to 2010, Independent Director at Pixium Vision SA, Director at Natus Medical, Inc., Lead Independent Director at DiaSorin SpA, Vice President-Europe, Middle East & Africa Region at Edwards Lifesciences Corp.
from 2000 to 2004, and President-CardioVascular Group at Baxter Cardiovascular Group.
Education includes an MBA from INSEAD in 1983 and undergraduate studies at École centrale de Lille.

Aktiva positioner av André-Michel Ballester

FöretagPositionStart
Privat kapitalinvesterare 2017-01-01
Företagsledare/Principal 2025-02-24

Tidigare kända positioner av André-Michel Ballester

FöretagPositionSlut
LIVANOVA PLC Verkställande Direktör 2016-12-31
MAUNA KEA TECHNOLOGIES Direktör/Styrelseledamot 2015-12-17
SORIN SPA Verkställande Direktör 2015-10-01
EDWARDS LIFESCIENCES CORPORATION Företagsledare/Principal -
Ordförande -
Se detaljerna i André-Michel Ballesters erfarenhet

André-Michel Ballesters utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

74

Första gradens relationer

16

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag16

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Process Industries

Health Technology

Consumer Services

Distribution Services

Commercial Services

Health Technology

Transportation

Baxter Cardiovascular Group

Health Technology

Finance

Health Technology

  1. Börsen
  2. Insiders
  3. André-Michel Ballester